UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

Annals of oncology, 2006-01, Vol.17 (1), p.123-130

2006

Volltextzugriff (PDF)

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

Annals of oncology, 2014-03, Vol.25 (3), p.669-674

2014

Volltextzugriff (PDF)

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

The New England journal of medicine, 2018-04, Vol.378 (15), p.1396-1407

2018

Volltextzugriff (PDF)

567 Genomic Analysis of Non-Hodgkin Lymphomas Reveals Mutations in Chromatin Remodelling Genes

European journal of cancer (1990), 2012-07, Vol.48, p.S135-S135

2012

Volltextzugriff (PDF)

Stromal Gene Signatures in Large-B-Cell Lymphomas

The New England journal of medicine, 2008-11, Vol.359 (22), p.2313-2323

2008

Volltextzugriff (PDF)

Observation as the initial management strategy in patients with mantle cell lymphoma

Annals of oncology, 2017-10, Vol.28 (10), p.2489-2495

2017

Volltextzugriff (PDF)

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

Annals of oncology, 2010-05, Vol.21 (5), p.1046-1052

2010

Volltextzugriff (PDF)

BCL2 mutations in diffuse large B-cell lymphoma

Leukemia, 2012-06, Vol.26 (6), p.1383-1390

2012

Volltextzugriff (PDF)

IL10 receptor is a novel therapeutic target in DLBCLs

Leukemia, 2015-08, Vol.29 (8), p.1684-1694

2015

Volltextzugriff (PDF)

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

Annals of oncology, 2004-10, Vol.15 (10), p.1467-1475

2004

Volltextzugriff (PDF)

A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency

Annals of oncology, 2007-01, Vol.18 (1), p.129-135

2007

Volltextzugriff (PDF)

The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study

Annals of oncology, 2016-06, Vol.27 (6), p.1095-1099

2016

Volltextzugriff (PDF)

VII. The role of the microenvironment in lymphoid cancers

Annals of oncology, 2011-06, Vol.22, p.iv47-iv50

2011

Volltextzugriff (PDF)

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma

Oncogene, 2015-03, Vol.34 (10), p.1231-1240

2015

Volltextzugriff (PDF)

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

Annals of oncology, 2007-01, Vol.18 (1), p.116-121

2007

Volltextzugriff (PDF)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients

Leukemia, 2014-02, Vol.28 (2), p.362-372

2014

Volltextzugriff (PDF)

Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy

Annals of oncology, 2013-02, Vol.24 (2), p.428-432

2013

Volltextzugriff (PDF)

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)

British journal of haematology, 2010-10, Vol.151 (2), p.143-151

2010

Volltextzugriff (PDF)

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by .sup.90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

Leukemia, 2017-02, Vol.31 (2), p.517

2017

Volltextzugriff (PDF)

Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy

Annals of oncology, 2011-05, Vol.22 (5), p.1164-1169

2011

Volltextzugriff (PDF)

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

Leukemia, 2007-11, Vol.21 (11), p.2332-2343

2007

Volltextzugriff (PDF)

Bcl-3/IgH translocation (14;19)(q32;q13) in Non-Hodgkin's Lymphomas

Leukemia & lymphoma, 2002, Vol.43 (4), p.813-816

2002

Volltextzugriff (PDF)

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project

Annals of oncology, 2009-04, Vol.20 (4), p.715-721

2009

Volltextzugriff (PDF)

Impact of whole genome amplification on analysis of copy number variants

Nucleic acids research, 2008-08, Vol.36 (13), p.e80-e80

2008

Volltextzugriff (PDF)

9202 Long-term outcomes for patients with limited stage, follicular lymphoma: involved regional radiotherapy versus involved nodal radiotherapy

European journal of cancer supplements, 2009, Vol.7 (2), p.560-561

2009

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(41)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Oncology
(31)
Middle Aged
(30)
Female
(28)
Male
(27)
Hematologic And Hematopoietic Diseases
(26)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(25)
Aged
(24)
Adult
(22)
Lymphoma
(22)
Prognosis
(21)
Aged, 80 And Over
(14)
Antineoplastic Agents
(13)
Hematology
(12)
Pharmacology. Drug Treatments
(12)
Lymphocytes B
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

567 Genomic Analysis of Non-Hodgkin Lymphomas Reveals Mutations in Chromatin Remodelling Genes

Stromal Gene Signatures in Large-B-Cell Lymphomas

Observation as the initial management strategy in patients with mantle cell lymphoma

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

BCL2 mutations in diffuse large B-cell lymphoma

IL10 receptor is a novel therapeutic target in DLBCLs

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency

The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study

VII. The role of the microenvironment in lymphoid cancers

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients

Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by .sup.90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

Bcl-3/IgH translocation (14;19)(q32;q13) in Non-Hodgkin's Lymphomas

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project

Impact of whole genome amplification on analysis of copy number variants

9202 Long-term outcomes for patients with limited stage, follicular lymphoma: involved regional radiotherapy versus involved nodal radiotherapy

Suchergebnisse filtern